Latest filing published 22 Dec 2025 for Medline Inc., €60.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -21.9%Entry US$43.63 · Close 23 Oct 2026 US$34.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles N. Mills: trading record in brief
Charles N. Mills discloses dealings in Medline Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 16 December 2025 and the latest from 18 December 2025.
Purchases make up the whole of the open-market record (2 purchases, €63.7M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
The latest filing, published on 22 December 2025, reports an open-market purchase of €60.3M in Medline Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles N. Mills
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,441,379 shares@ US$29.0094.7% of flowClass A Common StockSEC:0001193125-25-328813:1Canonical exit: 18 Mar 2026 (T+90)
- 137,931 shares@ US$29.005.3% of flowClass A Common StockSEC:0001193125-25-328813:2Canonical exit: 18 Mar 2026 (T+90)
- 64,005 sharesClass B Common StockSEC:0001193125-25-328813:0
3 of 3 declarations
